Conserving the axilla in breast cancer.

axillary node clearance axillary node metastasis breast cancer primary systemic therapy radiotherapy sentinel node biopsy

Journal

Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236

Informations de publication

Date de publication:
2020
Historique:
received: 24 04 2020
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 6 10 2020
Statut: epublish

Résumé

It is recognised that surgical conservatism is the most effective way of managing the axilla in breast cancer patients undergoing primary breast conserving surgery. The extended clinical scenarios in which a less aggressive approach can be safely adopted warrant consideration-including a group of patients who potentially could bypass surgical staging of the axilla altogether. The application of omission of further surgical management and axillary radiotherapy in the primary surgical and neoadjuvant chemotherapy settings are considered.

Identifiants

pubmed: 33014132
doi: 10.3332/ecancer.2020.1090
pii: can-14-1090
pmc: PMC7498271
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1090

Informations de copyright

© the authors; licensee ecancermedicalscience.

Déclaration de conflit d'intérêts

The authors have no disclosures to make concerning financial or personal relationships that could inappropriately influence their work.

Références

Ann Surg Oncol. 2013 Dec;20(13):4145-52
pubmed: 23959051
J Clin Oncol. 2015 Jan 20;33(3):258-64
pubmed: 25452445
JAMA. 2011 Feb 9;305(6):569-75
pubmed: 21304082
Br J Cancer. 2013 Dec 10;109(12):2959-64
pubmed: 24157828
Lancet Oncol. 2013 Jun;14(7):609-18
pubmed: 23683750
Ann Surg. 2016 Apr;263(4):802-7
pubmed: 26649589
Lancet Oncol. 2010 Oct;11(10):927-33
pubmed: 20863759
Ann Surg Oncol. 2002 Oct;9(8):745-53
pubmed: 12374657
BMC Cancer. 2017 May 26;17(1):379
pubmed: 28549453
J Clin Oncol. 2016 Apr 1;34(10):1072-8
pubmed: 26811528
Breast. 2012 Oct;21(5):678-81
pubmed: 22835916
Int Semin Surg Oncol. 2009 Feb 09;6:5
pubmed: 19203387
Breast Cancer Res Treat. 2017 Nov;166(2):329-336
pubmed: 28755147
J Clin Oncol. 2014 May 1;32(13):1365-83
pubmed: 24663048
Future Oncol. 2019 Jan;15(2):207-224
pubmed: 30156427
Lancet Oncol. 2014 Nov;15(12):1303-10
pubmed: 25439688
Trials. 2018 Dec 4;19(1):667
pubmed: 30514362
AJR Am J Roentgenol. 2006 May;186(5):1342-8
pubmed: 16632729
Clin Oncol (R Coll Radiol). 2016 Sep;28(9):594-6
pubmed: 27342951
Eur J Surg Oncol. 2014 Oct;40(10):1203-8
pubmed: 25186914
Geburtshilfe Frauenheilkd. 2017 Feb;77(2):149-157
pubmed: 28331237
Geburtshilfe Frauenheilkd. 2019 Jun;79(6):591-604
pubmed: 31217628
Breast Cancer Res Treat. 2019 Aug;177(1):1-4
pubmed: 31152326
Lancet Oncol. 2013 Apr;14(4):297-305
pubmed: 23491275
Ann Surg. 2012 Sep;256(3):428-36
pubmed: 22868365
J Clin Oncol. 2008 Feb 10;26(5):778-85
pubmed: 18258986
Ann Surg. 2015 Feb;261(2):378-82
pubmed: 24743607
Eur J Cancer. 2014 Nov;50(16):2763-70
pubmed: 25240289

Auteurs

Felix Jozsa (F)

https://orcid.org/0000-0001-8960-6049.

Muneer Ahmed (M)

https://orcid.org/0000-0002-4504-1354.

Classifications MeSH